European Innovation Council

The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.

David Malo Jean

Director

Candace Johnson

President

Past deals in Ireland

Bluedrop Medical

Venture Round in 2023
Bluedrop Medical Limited specializes in developing, manufacturing, and commercializing an Internet of Things-enabled device designed for the early detection of diabetic foot ulcers. Founded in 2014 and based in Galway, Ireland, the company offers a home-based system that conducts daily scans of patients' feet. This data is then transmitted to the cloud for analysis using advanced algorithms capable of identifying abnormalities. By detecting skin damage early, the device aims to significantly reduce the risk of amputation, which is a critical concern as up to 25% of individuals with diabetes may develop foot ulcers, often due to peripheral neuropathy. The innovative technology not only enhances patient care but also has the potential to lower healthcare costs associated with severe complications arising from untreated foot ulcers.

Nemysis

Grant in 2023
Nemysis Limited is a specialty pharmaceutical company founded in 2005 and based in Dublin, Ireland. The company focuses on addressing unmet needs in nutritional disorders and deficiencies through a unique staged approach to product development. Nemysis manufactures a range of food supplements, medical matrix products, and prescription items, targeting the same medical conditions across different market segments. Notable products include a novel gastric and trypsin-resistant formulation designed for oral enzymatic therapy in patients with celiac disease, as well as an iron supplement that acts as a medical device to neutralize gluten, aimed at alleviating symptoms for individuals with celiac disease and non-celiac gluten sensitivity. This strategy allows Nemysis to cater to patients with iron deficiency or anemia while minimizing gastrointestinal side effects associated with traditional iron supplementation.

Ostoform

Grant in 2022
Ostoform is a spin-out medical device company from the University of Limerick, Ireland with a range of patented technologies, and the potential to scale, becoming a global leader in the area of ostomy skin health.

AuriGen Medical

Grant in 2022
AuriGen Medical Limited is an electrophysiology and structural heart company based in Dublin, Ireland, founded in 2016. The company focuses on developing innovative left atrial appendage (LAA) implants designed to address the stroke and arrhythmia risks associated with persistent atrial fibrillation (AF). AuriGen's technology targets highly symptomatic patients who are resistant to medication, a demographic that includes over 3 million individuals in the United States and Europe. The rising incidence of AF, particularly among aging populations, underscores the urgent need for effective treatment alternatives. AuriGen's devices incorporate custom LAA occluder implants and are designed to enhance patient outcomes by reducing reliance on anticoagulants and anti-arrhythmic medications. With the annual costs of managing medication-resistant AF running into billions, AuriGen aims to provide cost-effective solutions that improve treatment efficacy and patient quality of life.

Loci Orthopaedics

Grant in 2022
Loci Orthopaedics Limited, based in Upper Newcastle, Ireland, specializes in developing innovative medical technologies to address significant unmet clinical needs in orthopedics. Founded in 2017, the company focuses on creating surgical implants, particularly the InDx implant, which is designed to treat arthritis in the thumb base joint. This implant uniquely mimics the natural motions of the thumb joint, offering a less invasive and easier insertion method compared to existing surgical options. Additionally, Loci Orthopaedics is known for its Osteoanchor surface architecture, which is based on evidence-based designs, enabling clinicians to effectively address challenges in orthopedic extremities.

Loci Orthopaedics

Venture Round in 2022
Loci Orthopaedics Limited, based in Upper Newcastle, Ireland, specializes in developing innovative medical technologies to address significant unmet clinical needs in orthopedics. Founded in 2017, the company focuses on creating surgical implants, particularly the InDx implant, which is designed to treat arthritis in the thumb base joint. This implant uniquely mimics the natural motions of the thumb joint, offering a less invasive and easier insertion method compared to existing surgical options. Additionally, Loci Orthopaedics is known for its Osteoanchor surface architecture, which is based on evidence-based designs, enabling clinicians to effectively address challenges in orthopedic extremities.

Bluedrop Medical

Venture Round in 2021
Bluedrop Medical Limited specializes in developing, manufacturing, and commercializing an Internet of Things-enabled device designed for the early detection of diabetic foot ulcers. Founded in 2014 and based in Galway, Ireland, the company offers a home-based system that conducts daily scans of patients' feet. This data is then transmitted to the cloud for analysis using advanced algorithms capable of identifying abnormalities. By detecting skin damage early, the device aims to significantly reduce the risk of amputation, which is a critical concern as up to 25% of individuals with diabetes may develop foot ulcers, often due to peripheral neuropathy. The innovative technology not only enhances patient care but also has the potential to lower healthcare costs associated with severe complications arising from untreated foot ulcers.

RemedyBio

Venture Round in 2021
RemedyBio is an immunology-focused discovery and development company located in Dublin, Ireland. The company specializes in creating therapeutics aimed at enhancing immunotherapies for complex diseases. RemedyBio has developed innovative technology that accelerates and scales single-cell analysis, which plays a crucial role in advancing treatments in areas such as immuno-oncology, autoimmune diseases, and infectious diseases. By leveraging this technology, RemedyBio seeks to provide the healthcare industry with more effective therapeutic and diagnostic solutions.

Vivasure Medical

Grant in 2021
Vivasure Medical Limited is a medical device company based in Galway, Ireland, specializing in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures in the fields of cardiology, interventional radiology, and vascular surgery. Its primary product is a large-bore percutaneous closure device that employs an absorbable patch to effectively close large arteriotomies following transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Established in 2008, Vivasure Medical is dedicated to advancing medical solutions that enhance patient outcomes in vascular access procedures.

Intelligent Implants

Grant in 2021
Intelligent Implants, founded in 2014 in Cork, Ireland, specializes in the development of wireless implantable electronics designed to stimulate, steer, and monitor bone growth. The company focuses on creating electrotherapeutic devices that not only treat diseases but also support the recovery of bone and other tissues. By integrating data, engineering, and medicine, Intelligent Implants aims to deliver innovative, active, and connected medical devices that enhance patient treatment and facilitate decision-making for healthcare professionals. Their technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to effectively utilize electrotherapeutics to monitor and control patient conditions, ultimately leading to more timely and informed medical interventions.

Contego Sports

Grant in 2021
Contego Sports Ltd was founded in Galway, Republic of Ireland by Mark and Dr Sandra Ganly, a couple who have combined their vast expertise in two different fields to develop this next generation head guard. Mark Ganly has over ten years’ experience in sports equipment design and manufacturing, while Dr Sandra Ganly has a PhD and extensive experience in the field of biomedical engineering and medical device innovation:

Provizio

Seed Round in 2020
Provizio Ltd is a technology company that specializes in accident prevention solutions aimed at enhancing vehicle safety. Founded in 2019 and headquartered in Limerick, Ireland, the company utilizes proprietary long-range imaging sensors and machine learning to detect potential dangers on the road. Its platform is designed to perceive, predict, and prevent automotive accidents in real-time, addressing the human errors that contribute to most road fatalities. By enabling drivers to see through obstacles and identify hazards in various weather conditions, Provizio aims to significantly reduce serious injuries and fatalities associated with road accidents. Additionally, the company offers a BETA program to further develop and test its technology.

SiriusXT

Grant in 2020
SiriusXT Limited, based in Dublin, Ireland, specializes in the development and manufacturing of a soft x-ray microscope known as the SXT system. Founded in 2015, the company primarily serves researchers in disease research and drug discovery. The microscope employs a vacuum-based laser-produced plasma light source, enabling high-resolution imaging of the 3D internal structure of cells in their native, fully hydrated state. This technology is akin to a CT scan for cells, allowing for detailed visualization without the need for stains or contrast agents. The SXT system is particularly beneficial for disease researchers, pharmaceutical companies, and biotechnologists, as it facilitates the understanding of disease pathways, protein-drug interactions, and bio-engineering processes. As the first high-throughput, bench-top soft x-ray microscope, SiriusXT's system can produce full cell 3D tomographs in a matter of minutes, significantly advancing imaging capabilities in scientific research.

SiriusXT

Venture Round in 2020
SiriusXT Limited, based in Dublin, Ireland, specializes in the development and manufacturing of a soft x-ray microscope known as the SXT system. Founded in 2015, the company primarily serves researchers in disease research and drug discovery. The microscope employs a vacuum-based laser-produced plasma light source, enabling high-resolution imaging of the 3D internal structure of cells in their native, fully hydrated state. This technology is akin to a CT scan for cells, allowing for detailed visualization without the need for stains or contrast agents. The SXT system is particularly beneficial for disease researchers, pharmaceutical companies, and biotechnologists, as it facilitates the understanding of disease pathways, protein-drug interactions, and bio-engineering processes. As the first high-throughput, bench-top soft x-ray microscope, SiriusXT's system can produce full cell 3D tomographs in a matter of minutes, significantly advancing imaging capabilities in scientific research.

Geowox

Grant in 2019
Geowox Limited specializes in providing AI-powered valuations for the residential real estate sector in Ireland and the UK. Established in 2017 and based in Dublin, the company offers a range of services tailored for lenders and investors. For lenders, Geowox facilitates new lead generation, property re-valuation, fraud detection, and alignment with capital requirements and non-performing loans. Investors benefit from tools that help assess new business opportunities, evaluate risks using data, and analyze market trends. Geowox also develops online workflow tools that automate home valuations, enhancing the digital mortgage process and ensuring efficient property assessments with RICS-certified sign-offs. By leveraging open data and machine learning, Geowox delivers instant sales comparables reports and neighborhood insights, streamlining the valuation process for clients.

Capri Medical

Venture Round in 2019
Capri Medical Limited, founded in 2018 and based in Galway, Ireland, specializes in developing neurostimulation devices aimed at treating chronic post-operative pain. The company's flagship product, Capri-Stim, is designed to intercept the patient pathway and provide neurostimulation to prevent percutaneous tissue damage. Capri Medical focuses on creating advanced implantable devices that stimulate the peripheral nervous system, addressing significant healthcare challenges. By leveraging a bioelectronics platform, the company aims to enhance patient comfort and improve treatment outcomes in various neurological indications.

Capri Medical

Grant in 2019
Capri Medical Limited, founded in 2018 and based in Galway, Ireland, specializes in developing neurostimulation devices aimed at treating chronic post-operative pain. The company's flagship product, Capri-Stim, is designed to intercept the patient pathway and provide neurostimulation to prevent percutaneous tissue damage. Capri Medical focuses on creating advanced implantable devices that stimulate the peripheral nervous system, addressing significant healthcare challenges. By leveraging a bioelectronics platform, the company aims to enhance patient comfort and improve treatment outcomes in various neurological indications.

Bluedrop Medical

Grant in 2019
Bluedrop Medical Limited specializes in developing, manufacturing, and commercializing an Internet of Things-enabled device designed for the early detection of diabetic foot ulcers. Founded in 2014 and based in Galway, Ireland, the company offers a home-based system that conducts daily scans of patients' feet. This data is then transmitted to the cloud for analysis using advanced algorithms capable of identifying abnormalities. By detecting skin damage early, the device aims to significantly reduce the risk of amputation, which is a critical concern as up to 25% of individuals with diabetes may develop foot ulcers, often due to peripheral neuropathy. The innovative technology not only enhances patient care but also has the potential to lower healthcare costs associated with severe complications arising from untreated foot ulcers.

Geowox

Seed Round in 2019
Geowox Limited specializes in providing AI-powered valuations for the residential real estate sector in Ireland and the UK. Established in 2017 and based in Dublin, the company offers a range of services tailored for lenders and investors. For lenders, Geowox facilitates new lead generation, property re-valuation, fraud detection, and alignment with capital requirements and non-performing loans. Investors benefit from tools that help assess new business opportunities, evaluate risks using data, and analyze market trends. Geowox also develops online workflow tools that automate home valuations, enhancing the digital mortgage process and ensuring efficient property assessments with RICS-certified sign-offs. By leveraging open data and machine learning, Geowox delivers instant sales comparables reports and neighborhood insights, streamlining the valuation process for clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.